| Name | Title | Contact Details |
|---|
Advantica Benefits is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Alta Bates Medical Group is a Emeryville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Herself Health is a primary care practice designed for women 65 and up, offering female-focused, age-conscious services that consider every part of health: physical, emotional, spiritual, sexual, and social. Herself Health provides person-centered, value-based care to women 65+ with a focus on mind, body, and soul. This holistic approach to care delivery aims to improve the quality of life of both the women for whom we care and the clinical team of physicians, nurses, and medical assistants. We realize that health is more than just healthcare and our goal is to help each Herself woman live her best life.
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.
C-TASC provides products and services to support responsible management of clinical trials, clinical surveys, case/control studies, clinical registries, clinical cohort studies and laboratory studies. For over 15 years C-TASC's services group has played nearly every role in studies of all sizes. Our experienced and professional medical and biostatistical staff can provide expertise in complete study design, data collection and management and data analysis. C-TASC's software group has developed, hosted and managed Web-based clinical data management systems for dozens of studies including the recent release of our SaaS product StudyCTMS.com, an end-to-end clinical trials management system (CTMS) including electronic data capture (EDC), integrated SAS, a drag and drop form builder and many other intuitive tools. StudyCTMS.com is an affordable solution for every investigator. Our location is convenient to Washington DC, Maryland, Philadelphia, and Southern New Jersey.